CANNABIS MARKET UPDATE APRIL 2026 – Straight Take – Real Operators versus Capital Destroyers
May 6, 2026
|
|
|

Increase of 16.4% in May
What Actually Matters (next 12 months)
While nearly all values in our portfolio have increased strongly, only if U.S. Rescheduling (the catalyst) is finalized will we see a sector-wide and consistent re-rating. If rescheduling is delayed, stocks will continue to trade sideways / grind. The growth is also driven by state-level dynamics, with Florida, New York, and Pennsylvania being the key growth drivers. At the same time, the largest market, California, continues to face significant margin pressure.

SWI Line Ranking – 12-Month Outlook
🟢 Best Bets
- Green Thumb
- Trulieve
- Curaleaf
🟡 Middle/selective Upside
- Cresco
- Glass House
- IIPR
- OrganiGram
- Cronos
🔴 High risk / weak Fundamentals
- Aurora
- Canopy
- Tilray (trading stock, not fundamental winner)
⚪ Speculative Microcaps
- LiveWire
- Verena
- WM Technologies

Although we saw a significant 16.4% increase in May and over the next ~2 months, this trend could continue; the cannabis market is unlikely to see a dramatic breakout or collapse. Instead, expect a choppy, sometimes sideways-trading market with a catalyst-driven holding pattern influenced by policy signals, including specific upcoming legislation or regulatory decisions, pricing pressure, and state-level dynamics. Short-term performance will likely be sideways to volatile with sharp spikes, rather than a clear upward or downward trend. Nevertheless, market Caps, for the first time in months, have increased across the board.
|
|
|
Search
RECENT PRESS RELEASES
Related Post


